Sonata Capital Group’s Bristol-Myers Squibb BMY Stock Holding History

Sonata Capital Group’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-4,179	Closed	-$233K	–	110
2020 Q1	$233K	Sell	4,179 -200	-5%	-$12.2K	0.18%	94
2019 Q4	$281K	Buy	+4,379	New	+$251K	0.17%	93
2019 Q2	–	Sell	-4,784	Closed	-$228K	–	106
2019 Q1	$228K	Hold	4,784	–	–	0.17%	93
2018 Q4	$249K	Sell	4,784 -251	-5%	-$13.5K	0.2%	88
2018 Q3	$313K	Sell	5,035 -530	-10%	-$31.5K	0.21%	86
2018 Q2	$308K	Buy	5,565 +530	+11%	+$28.6K	0.22%	85
2018 Q1	$318K	Hold	5,035	–	–	0.23%	84
2017 Q4	$309K	Hold	5,035	–	–	0.22%	88
2017 Q3	$321K	Hold	5,035	–	–	0.24%	87
2017 Q2	$281K	Hold	5,035	–	–	0.21%	87
2017 Q1	$274K	Hold	5,035	–	–	0.21%	88
2016 Q4	$294K	Hold	5,035	–	–	0.23%	86
2016 Q3	$271K	Buy	5,035 +2,250	+81%	+$145K	0.22%	87
2016 Q2	$205K	Buy	+2,785	New	+$197K	0.17%	92

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Sonata Capital Group's BMY Position: Q2 2020 in Review

Sonata Capital Group sold out of Bristol-Myers Squibb (BMY) in Q2 2020, closing a stake of 4,179 shares — an estimated $233K sold.

Sonata Capital Group first reported a position in BMY in Q2 2016 and held it in 14 quarters. The position peaked at $321K in Q3 2017. 2,190 funds tracked by Wall St. Rank hold BMY as of Q2 2020.

Sonata Capital Group reported no remaining Bristol-Myers Squibb position as of Q2 2020 after selling out during the quarter.
Sonata Capital Group sold 4,179 Bristol-Myers Squibb shares in Q2 2020, an estimated $233K.
Sonata Capital Group first reported a position in Bristol-Myers Squibb in Q2 2016 and held it in 14 quarters.
Sonata Capital Group's Bristol-Myers Squibb position peaked at $321K in Q3 2017.
2,190 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2020.

Based on Sonata Capital Group's 13F filing for Q2 2020, filed 3 Aug 2020.